Polymyositis News and Research

RSS
Polymyositis is a fairly uncommon condition that leads to increasing weakness of the skeletal muscles (those muscles involved in movement) and it can affect the body bilaterally (on both sides).

Further Reading

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Anti-TNF therapy offers new hope to JDM patients

Anti-TNF therapy offers new hope to JDM patients

Idera begins enrollment in IMO-8400 Phase 2 clinical trial for treatment of dermatomyositis

Idera begins enrollment in IMO-8400 Phase 2 clinical trial for treatment of dermatomyositis

Clinical study data on Mallinckrodt's H.P. Acthar Gel to be presented at ACR 2015

Clinical study data on Mallinckrodt's H.P. Acthar Gel to be presented at ACR 2015

Former all-American wrestler speaks about his personal battle with chronic muscle disease

Former all-American wrestler speaks about his personal battle with chronic muscle disease

Researchers identify link between autoimmune diseases, medications and Long QT syndrome

Researchers identify link between autoimmune diseases, medications and Long QT syndrome

Idera collaborates with TMA to advance new potential treatment approach for myositis

Idera collaborates with TMA to advance new potential treatment approach for myositis

Bristol-Myers Squibb to present new immunotherapy study data at ASCO Annual Meeting

Bristol-Myers Squibb to present new immunotherapy study data at ASCO Annual Meeting

Idera Pharmaceuticals reports positive top-line results from Phase 2 trial of IMO-8400

Idera Pharmaceuticals reports positive top-line results from Phase 2 trial of IMO-8400

Questcor acquires rights to develop Synacthen and Synacthen Depot in US

Questcor acquires rights to develop Synacthen and Synacthen Depot in US

Janssen announces U.S. prescribing information update for EDURANT tablets

Janssen announces U.S. prescribing information update for EDURANT tablets

Questcor second quarter net sales increase to $112.5 million

Questcor second quarter net sales increase to $112.5 million

Questcor fourth quarter net sales increase to $75.5 million

Questcor fourth quarter net sales increase to $75.5 million

Most autoimmune diseases associated with increased risk of blood clots on the lung

Most autoimmune diseases associated with increased risk of blood clots on the lung

Vitamin D deficiency could be linked to development of certain autoimmune lung diseases

Vitamin D deficiency could be linked to development of certain autoimmune lung diseases

Questcor's H.P. Acthar Gel sNDA for infantile spasms receives FDA approval

Questcor's H.P. Acthar Gel sNDA for infantile spasms receives FDA approval

AARDA launches campaign on family AQ

AARDA launches campaign on family AQ

March designated as 'National Autoimmune Diseases Awareness Month'

March designated as 'National Autoimmune Diseases Awareness Month'

Researchers receive grant to study how ILD appears in patients with autoimmune diseases

Researchers receive grant to study how ILD appears in patients with autoimmune diseases

Polymyositis and dermatomyositis affected patients more prone to cardiovascular diseases

Polymyositis and dermatomyositis affected patients more prone to cardiovascular diseases